Biocardia, INC Schedule 13G passive stakes

Intracoastal Capital, along with Mitchell P. Kopin and Daniel B. Asher, reported a 4.99% passive beneficial ownership stake in BioCardia, Inc. common stock.

Lincoln Alternative Strategies LLC has reported a beneficial ownership of 7.54% in BioCardia, Inc., holding 800,000 shares of common stock.

Thomas A. Satterfield, Jr. has increased his beneficial ownership in BioCardia, Inc. to 9.9% of the common stock, including shares and exercisable warrants.

Thomas A. Satterfield, Jr. has filed an amended Schedule 13G, disclosing a beneficial ownership of 8.2% of BioCardia, Inc.'s common stock as of December 31, 2024.